Developing and Validating Risk Assessment Models of Clinical Outcomes in Modern Oncology.
Journal
JCO precision oncology
ISSN: 2473-4284
Titre abrégé: JCO Precis Oncol
Pays: United States
ID NLM: 101705370
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
17
12
2019
pubmed:
17
12
2019
medline:
17
12
2019
Statut:
ppublish
Résumé
The identification of prognostic factors and building of risk assessment prognostic models will continue to play a major role in 21
Identifiants
pubmed: 31840130
doi: 10.1200/PO.19.00068
pmc: PMC6908945
mid: NIHMS1061871
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NINDS NIH HHS
ID : R01 NS091307
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA195424
Pays : United States
Références
Diagn Progn Res. 2018;2:
pubmed: 30393771
J Clin Oncol. 2013 May 10;31(14):1740-7
pubmed: 23569308
Biometrics. 2003 Sep;59(3):676-85
pubmed: 14601769
CA Cancer J Clin. 2016 Sep;66(5):370-4
pubmed: 26784705
Pharm Stat. 2019 Mar;18(2):126-139
pubmed: 30592133
J R Stat Soc Series B Stat Methodol. 2008;70(5):903
pubmed: 19603084
Stat Med. 2011 Oct 30;30(24):2867-80
pubmed: 21815180
Nature. 2013 Sep 19;501(7467):355-64
pubmed: 24048068
J Biomed Inform. 2004 Aug;37(4):249-59
pubmed: 15465478
Stat Med. 2015 May 30;34(12):2035-47
pubmed: 25736915
Lancet. 2010 Aug 28;376(9742):687-97
pubmed: 20728210
Semin Oncol. 2010 Apr;37(2):e9-18
pubmed: 20494694
Lancet Oncol. 2015 Apr;16(4):417-25
pubmed: 25743937
NPJ Breast Cancer. 2018 May 22;4:11
pubmed: 29845110
Comput Stat Data Anal. 2019 Jan;129:14-29
pubmed: 30559575
Stat Methods Med Res. 2019 Dec;28(12):3649-3666
pubmed: 30463497
J Clin Oncol. 2014 Mar 1;32(7):671-7
pubmed: 24449231
Nature. 2013 Sep 19;501(7467):346-54
pubmed: 24048067
Biometrics. 2013 Mar;69(1):206-13
pubmed: 23379600
Biometrics. 2005 Mar;61(1):92-105
pubmed: 15737082
J Biopharm Stat. 2014;24(1):130-53
pubmed: 24392982
Ann Oncol. 2015 Jun;26(6):1254-1262
pubmed: 25862439
J Clin Oncol. 1983 Nov;1(11):710-9
pubmed: 6668489
Biomed Res Int. 2016;2016:8209453
pubmed: 27597974
Stat Med. 2017 Oct 30;36(24):3820-3829
pubmed: 28707701
Stat Med. 2009 Jul 10;28(15):1982-98
pubmed: 19452569
N Engl J Med. 2018 Jul 12;379(2):111-121
pubmed: 29860917
J Clin Oncol. 2018 Sep 1;36(25):2621-2629
pubmed: 30040523
Stat Med. 2017 Jan 15;36(1):136-196
pubmed: 27488683
Milbank Q. 2004;82(4):661-87
pubmed: 15595946
Biostatistics. 2000 Dec;1(4):465-80
pubmed: 12933568
J Clin Oncol. 2010 Aug 10;28(23):3762-9
pubmed: 20625132
J Clin Epidemiol. 2016 Jan;69:245-7
pubmed: 25981519
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Biometrics. 1997 Mar;53(1):330-9
pubmed: 9147598
Stat Methods Med Res. 2016 Dec;25(6):2972-2991
pubmed: 24847900
Stat Methods Med Res. 2019 Feb;28(2):327-342
pubmed: 28750578
J Clin Oncol. 2003 Apr 1;21(7):1232-7
pubmed: 12663709
Ann Appl Stat. 2017 Sep;11(3):1787-1809
pubmed: 29081873
Biom J. 2017 Nov;59(6):1277-1300
pubmed: 28508545
PLoS Med. 2014 Oct 14;11(10):e1001744
pubmed: 25314315
Science. 1976 Oct 1;194(4260):23-8
pubmed: 959840
Clin J Am Soc Nephrol. 2011 Jul;6(7):1731-8
pubmed: 21734089
J Clin Oncol. 2012 May 1;30(13):1534-40
pubmed: 22454414
Breast Cancer Res. 2010;12(1):R1
pubmed: 20053270
J Clin Epidemiol. 2013 Aug;66(8):818-25
pubmed: 23651763
Biostatistics. 2009 Jul;10(3):535-49
pubmed: 19369642
Biometrics. 2015 Mar;71(1):178-187
pubmed: 25223432
Biom J. 2017 Nov;59(6):1261-1276
pubmed: 28792080
Biometrics. 2011 Sep;67(3):819-29
pubmed: 21306352
J Multivar Anal. 2012 Feb 1;105(1):397-411
pubmed: 22408278
J Clin Oncol. 2004 Jul 1;22(13):2567-75
pubmed: 15226324
Trials. 2009 Jun 19;10:43
pubmed: 19545379
Stat Med. 1997 Feb 28;16(4):385-95
pubmed: 9044528
Clin Trials. 2010 Oct;7(5):574-83
pubmed: 20667935
Ann Neurol. 1998 Sep;44(3 Suppl 1):S160-6
pubmed: 9749589
Biometrics. 2005 Jun;61(2):379-91
pubmed: 16011684
Biometrics. 2016 Sep;72(3):907-16
pubmed: 26890381